Literature DB >> 3278913

The distribution of two hnRNP-associated proteins defined by a monoclonal antibody is altered in heat-shocked HeLa cells.

Y Lutz1, M Jacob, J P Fuchs.   

Abstract

A monoclonal antibody obtained after mice were immunized with hnRNP purified from HeLa cells recognizes two polypeptides of Mr 35,000 and 37,000. By immunocytofluorescence, these antigens can be visualized only in cells previously heat shocked at 45 degrees C for 5 or 10 min, although they are present at the same level in unstressed and stressed cells. The signal, which is mostly concentrated in the interchromatin space, where hnRNP fibrils are located, does not accumulate with time and disappears 4 to 5 h after heat shock. Discrimination between the two types of hnRNP substructures, the 30-50 S monoparticles and the nuclear matrix fibrils, based on differential sensitivity to salt or ribonuclease treatment, showed that in unstressed cells the antigens behave as monoparticle proteins. In contrast, in heat-shocked cells, most 35-37K antigens behave as nuclear matrix proteins. Thus, heat shock seems to induce a rapid and reversible switch of these two antigens from hnRNP monoparticles to the nuclear matrix. The data demonstrate that heat shock, which was previously shown not to alter the overall RNA: protein packaging ratio of hnRNP, induces subtle modifications of their substructure. Such modifications might be of importance since heat shock is known for instance to affect pre-mRNA processing.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3278913     DOI: 10.1016/0014-4827(88)90259-5

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  15 in total

1.  Reassembly and protection of small nuclear ribonucleoprotein particles by heat shock proteins in yeast cells.

Authors:  A P Bracken; U Bond
Journal:  RNA       Date:  1999-12       Impact factor: 4.942

2.  Change in the expression of a nuclear matrix-associated protein is correlated with cellular transformation.

Authors:  C Brancolini; C Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

Review 3.  Heterogeneous nuclear ribonucleoprotein complexes.

Authors:  M S Swanson
Journal:  Mol Biol Rep       Date:  1990       Impact factor: 2.316

4.  The human hnRNP-M proteins: structure and relation with early heat shock-induced splicing arrest and chromosome mapping.

Authors:  R Gattoni; D Mahé; P Mähl; N Fischer; M G Mattei; J Stévenin; J P Fuchs
Journal:  Nucleic Acids Res       Date:  1996-07-01       Impact factor: 16.971

5.  Properties of the adenovirus IVa2 gene product, an effector of late-phase-dependent activation of the major late promoter.

Authors:  P Lutz; C Kedinger
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

6.  Alternative 5' splice site selection induced by heat shock.

Authors:  H Takechi; N Hosokawa; K Hirayoshi; K Nagata
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

7.  The acidic transcriptional activator GAL-VP16 acts on preformed template-committed complexes.

Authors:  J White; C Brou; J Wu; Y Lutz; V Moncollin; P Chambon
Journal:  EMBO J       Date:  1992-06       Impact factor: 11.598

8.  A novel splicing factor is an integral component of 200S large nuclear ribonucleoprotein (InRNP) particles.

Authors:  G Ast; D Goldblatt; D Offen; J Sperling; R Sperling
Journal:  EMBO J       Date:  1991-02       Impact factor: 11.598

9.  Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins.

Authors:  P Kastner; A Perez; Y Lutz; C Rochette-Egly; M P Gaub; B Durand; M Lanotte; R Berger; P Chambon
Journal:  EMBO J       Date:  1992-02       Impact factor: 11.598

10.  Characterization and cloning of the human splicing factor 9G8: a novel 35 kDa factor of the serine/arginine protein family.

Authors:  Y Cavaloc; M Popielarz; J P Fuchs; R Gattoni; J Stévenin
Journal:  EMBO J       Date:  1994-06-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.